Tencent co-leads China's SanegeneBio's extended Series A round - DealStreetAsia

Retrieved on: 2023-12-02 00:23:25

Tags for this article:

Corporate finance

Oriza Holdings

Qiming Venture Partners

Venture capital

RNA interference

Tencent

Click the tags to see associated articles and topics

Tencent co-leads China's SanegeneBio's extended Series A round - DealStreetAsia. View article details on hiswai:

Excerpt

... Capital Group, according to a company announcement on Friday. Existing shareholders Qiming Venture Partners, Alwin Capital, TF Capital, and K2VC ...

Article found on: www.dealstreetasia.com

View Original Article